Yuzhi Wang

498 citations
15 papers · 364 indexed · h-index 9
Topics
Ginseng Biological Effects and Applications (3 papers)Liver Disease Diagnosis and Treatment (3 papers)Fibroblast Growth Factor Research (2 papers)
Partner nations
ChinaSingaporePoland

In The Last Decade

Yuzhi Wang

15 papers receiving 355 citations

Peers

Yuzhi Wang
Comparison fields: 5 of 82
  • Molecular Biology 210
  • Cancer Research 86
  • Pharmacology 74
  • Plant Science 46
  • Cell Biology 39
Replace Hailun Gu with:
Hailun Gu China
Fang Yao China
Jiahua Wei China
Wenjing Fan China
Yu Yeon Jung South Korea
An-Na Chiang Taiwan
Yuming Huang China
Xiaohan Yuan China
Xiaojuan Feng China
Yi Yan China
Yuzhi Wang relative to Hailun Gu China Hailun Gu's profile →
Citations per field
00.5×9.2×
Hailun Gu · 1×
Citations per year

Countries citing papers authored by Yuzhi Wang

Since Specialization
Citations

This map shows the geographic impact of Yuzhi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuzhi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuzhi Wang more than expected).

Fields of papers citing papers by Yuzhi Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuzhi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuzhi Wang. The network helps show where Yuzhi Wang may publish in the future.

Co-authorship network of co-authors of Yuzhi Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yuzhi Wang. A scholar is included among the top collaborators of Yuzhi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuzhi Wang. Yuzhi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 50
2 6
3 7
4 32
5 23
6 55
7 24
8 5
9 42
10 37
11 20
12 53
13
[Non-apoptotic programmed cell death induced by extract of Spatholobus suberctus in human lung cancer A549 cells].
3
14 3
15 4

About Yuzhi Wang

Yuzhi Wang is a scholar working on Nephrology, Biochemistry and Cancer Research, having authored 15 papers that have together received 364 indexed citations. Recurring topics across this work include Ginseng Biological Effects and Applications (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and Fibroblast Growth Factor Research (2 papers). The work is most often cited by research in Cancer Research (86 citations), Pharmacology (74 citations) and Nephrology (25 citations). Yuzhi Wang has collaborated with scholars based in China, Singapore and Poland. Frequent co-authors include Guiyuan Lv, Suhong Chen, Shanshan Lei, Xinglishang He, Xiang Zheng, Lianghui Zhan, Meiqiu Yan, Jie Su, Tongyu Zhu and Hong Li. Their work appears in journals such as International Journal of Biological Macromolecules, The International Journal of Biochemistry & Cell Biology and Signal Transduction and Targeted Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026